Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bhisitkul

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Ophthalmology|June 21, 2011
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III studyDavid M Brown, Peter A Campochiaro, Robert B Bhisitkul, et al.
Eye (London, England)|November 30, 2023
Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patientsDaniel S Pereira, Raj K Maturi, Kazumasa Akita, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 12, 2017
Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agentJean Kim, Max Kudisch, Nina Rosa Konichi da Silva, et al.
Investigative Ophthalmology & Visual Science|April 19, 2008
Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhageRobert B Bhisitkul, Bryan J Winn, On-Tat Lee, et al.
Investigative Ophthalmology & Visual Science|November 13, 2015
In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular DeviceKevin D Lance, Samuel D Good, Thaís S Mendes, et al.
Investigative Ophthalmology & Visual Science|October 27, 2004
BDNF reduces the retinal toxicity of verteporfin photodynamic therapyDaniel M Paskowitz, George Nune, Douglas Yasumura, et al.
NEJM Evidence|April 22, 2025
Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular EdemaSharon Klier, Jamie Dananberg, Lauren Masaki, et al.
Drug Delivery and Translational Research|May 15, 2016
In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film deviceKevin D Lance, Daniel A Bernards, Natalie A Ciaccio, et al.
Retina (Philadelphia, Pa.)|December 29, 2000
Soccer ball-related retinal injuries: a report of 13 casesE P Horn, H R McDonald, R N Johnson, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Ophthalmology|June 21, 2011
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III studyDavid M Brown, Peter A Campochiaro, Robert B Bhisitkul, et al.
Eye (London, England)|November 30, 2023
Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patientsDaniel S Pereira, Raj K Maturi, Kazumasa Akita, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 12, 2017
Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agentJean Kim, Max Kudisch, Nina Rosa Konichi da Silva, et al.
Investigative Ophthalmology & Visual Science|April 19, 2008
Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhageRobert B Bhisitkul, Bryan J Winn, On-Tat Lee, et al.
Investigative Ophthalmology & Visual Science|November 13, 2015
In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular DeviceKevin D Lance, Samuel D Good, Thaís S Mendes, et al.
Investigative Ophthalmology & Visual Science|October 27, 2004
BDNF reduces the retinal toxicity of verteporfin photodynamic therapyDaniel M Paskowitz, George Nune, Douglas Yasumura, et al.
NEJM Evidence|April 22, 2025
Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular EdemaSharon Klier, Jamie Dananberg, Lauren Masaki, et al.
Drug Delivery and Translational Research|May 15, 2016
In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film deviceKevin D Lance, Daniel A Bernards, Natalie A Ciaccio, et al.
Retina (Philadelphia, Pa.)|December 29, 2000
Soccer ball-related retinal injuries: a report of 13 casesE P Horn, H R McDonald, R N Johnson, et al.
Pageof 6